New Jersey A 1824: Requires health care practitioners to inform patients of addiction potential of controlled dangerous substances prior to issuing prescription.

Status: Introduced in the Assembly, Referred to Assembly Health and Senior Services Committee (as of 2016-01-27)

State: New Jersey · Session: 217 · Bill: A 1824

Subjects: DRUG ABUSE, HEALTH PROF, PHARMACEUTIC

Sponsors: Benson, Daniel R., Conaway, Herb, Lagana, Joseph A., Lampitt, Pamela R., Mukherji, Raj, O'Scanlon, Declan J., Vainieri Huttle, Valerie, Ciattarelli, Jack M., Coughlin, Craig J., Gusciora, Reed, Singleton, Troy

View New Jersey A 1824 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.